Wellcome Leap Program 2026 for Research Institutions (Up to $50 Million Funding)
The Wellcome Leap Program is inviting proposals focused on reformulating existing antibiotics to protect the gut microbiome while maintaining treatment efficacy. This initiative aims to significantly reduce antibiotic-driven resistant infections globally, potentially avoiding over 100 million cases within a decade.
Eligible performers include universities, research institutions, and companies of all sizes. The program offers substantial funding, with a total budget of up to $50 million, to support innovative research proposals that align with its goals.
Eligibility
Open to performers from universities, research institutions, small, medium, and large companies, as well as government or non-profit research organizations.
Benefits
Funding will vary based on proposal scope, covering full direct and government-certified indirect costs appropriate for research execution.
